Search Tag: Tyra Biosciences
Tyra-biosciences-announces-planned-chief-financial-officer-transition
2022 02 Nov
- Esther van den Boom to transition to an advisor at year-end 2022- - Alan Fuhrman to be named Chief Financial Officer- Tyra Biosciences, Inc, a precision oncology company focused on developing purpose-built therapies to overcome tumor resistance and improve outcomes for patients with cancer announced that its Chief Financial Officer, ...Read more